(–)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin
Abstract
1. Introduction
2. Materials and Methods
2.1. Reagents
2.2. Cell Cultures
2.3. Cell Viability Analysis
2.4. Mammosphere Formation Assay and Chemical Treatment
2.5. Preparation of Total RNA and Real-Time Reverse Transcription-Polymerase Chain Reaction (Real-Time RT-PCR) Analysis
2.6. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kamboj, A.; Saluja, A. Phytopharmacological review of Xanthium strumarium L. (Cocklebur). Int. J. Green Pharm. 2010, 4, 129–139. [Google Scholar] [CrossRef]
- Fan, W.; Fan, L.; Peng, C.; Zhang, Q.; Wang, L.; Li, L.; Wang, J.; Zhang, D.; Peng, W.; Wu, C. Traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology of Xanthium strumarium L.: A review. Molecules 2019, 24, 359. [Google Scholar] [CrossRef] [PubMed]
- Roussakis, C.; Chinou, I.; Vayas, C.; Harvala, C.; Verbist, J.F. Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumarium. Planta Med. 1994, 60, 473–474. [Google Scholar] [CrossRef] [PubMed]
- Ramírez-Erosa, I.; Huang, Y.; Hickie, R.A.; Sutherland, R.G.; Barl, B. Xanthatin and xanthinosin from the burs of Xanthium strumarium L. as potential anticancer agents. Can. J. Physiol. Pharmacol. 2007, 85, 1160–1172. [Google Scholar] [CrossRef]
- Takeda, S.; Matsuo, K.; Yaji, K.; Okajima-Miyazaki, S.; Harada, M.; Miyoshi, H.; Okamoto, Y.; Amamoto, T.; Shindo, M.; Omiecinski, C.J.; et al. (–)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells. Chem. Res. Toxicol. 2011, 24, 855–865. [Google Scholar] [CrossRef]
- Takeda, S.; Noguchi, M.; Matsuo, K.; Yamaguchi, Y.; Kudo, T.; Nishimura, H.; Okamoto, Y.; Amamoto, T.; Shindo, M.; Omiecinski, C.J.; et al. (–)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: Role of topoisomerase IIα inhibition and reactive oxygen species. Toxicology 2013, 305, 1–9. [Google Scholar] [CrossRef]
- Takeda, S.; Nishimura, H.; Koyachi, K.; Matsumoto, K.; Yoshida, K.; Okamoto, Y.; Amamoto, T.; Shindo, M.; Aramaki, H. (–)-Xanthatin induces the prolonged expression of c-Fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells. J. Toxicol. Sci. 2013, 38, 547–557. [Google Scholar] [CrossRef]
- Li, W.D.; Wu, Y.; Zhang, L.; Yan, L.G.; Yin, F.Z.; Ruan, J.S.; Chen, Z.P.; Yang, G.M.; Yan, C.P.; Zhao, D.; et al. Characterization of xanthatin: Anticancer properties and mechanisms of inhibited murine melanoma in vitro and in vivo. Phytomedicine 2013, 20, 865–873. [Google Scholar] [CrossRef]
- Takeda, S.; Okajima, S.; Miyoshi, H.; Koyachi, K.; Matsumoto, K.; Shindo, M.; Aramaki, H. (–)-Xanthatin-mediated marked up-regulation of RhoB, a sensor for damaged DNA. Fundam. Toxicol. Sci. 2015, 2, 233–238. [Google Scholar] [CrossRef][Green Version]
- Yu, Y.; Yu, J.; Pei, C.G.; Li, Y.Y.; Tu, P.; Gao, G.P.; Shao, Y. Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells. Int. J. Clin. Exp. Pathol. 2015, 8, 10355–10364. [Google Scholar]
- Takeda, S.; Okajima, S.; Noguchi, M.; Miyoshi, H.; Koyachi, K.; Matsumoto, K.; Shindo, M.; Aramaki, H. Possible involvement of FosB in (–)-xanthatin-mediated anti-proliferative effects in human cancer MDA-MB-231 cells. Fundam. Toxicol. Sci. 2016, 3, 115–119. [Google Scholar] [CrossRef]
- Tao, L.; Sheng, X.; Zhang, L.; Li, W.; Wei, Z.; Zhu, P.; Zhang, F.; Wang, A.; Woodgett, J.R.; Lu, Y. Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3β and β-catenin. Biochem. Pharmacol. 2016, 115, 18–27. [Google Scholar] [CrossRef]
- Matsuo, K.; Ohtsuki, K.; Yoshikawa, T.; Shisho, K.; Yokotani-Tomita, K.; Shindo, M. Total synthesis of xanthanolides. Tetrahedron 2010, 66, 8407–8419. [Google Scholar] [CrossRef]
- Matsumoto, K.; Koyachi, K.; Shindo, M. Asymmetric total syntheses of xanthatin and 11,13-dihydroxanthatin using a stereocontrolled conjugate allylation to γ-butenolide. Tetrahedron 2013, 69, 1043–1049. [Google Scholar] [CrossRef]
- Humayun, A.; Fornace, A.J. GADD45 in stress signaling, cell cycle control, and apoptosis. Adv. Exp. Med. Biol. 2022, 1360, 1–22. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Li, Y.; Ji, J.; Wang, X.; Zhang, M.; Li, X.; Zhang, Y.; Zhu, Z.; Ye, S.-D.; Wang, X. Gadd45g initiates embryonic stem cell differentiation and inhibits breast cell carcinogenesis. Cell death Discov. 2021, 7, 271. [Google Scholar] [CrossRef]
- Wesolowski, R.; Ramaswamy, B. Gene expression profiling: Changing face of breast cancer classification and management. Gene Expr. 2011, 15, 105–115. [Google Scholar] [CrossRef]
- Wang, X.; Zhang, H.; Chen, X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2019, 2, 141–160. [Google Scholar] [CrossRef]
- Zhang, Q.; Feng, Y.; Kennedy, D. Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this? Cell. Mol. Life Sci. 2017, 74, 777–801. [Google Scholar] [CrossRef]
- Mani, S.A.; Guo, W.; Liao, M.J.; Eaton, E.N.; Ayyanan, A.; Zhou, A.Y.; Brooks, M.; Reinhard, F.; Zhang, C.C.; Shipitsin, M.; et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133, 704–715. [Google Scholar] [CrossRef]
- Gupta, P.B.; Onder, T.T.; Jiang, G.; Tao, K.; Kuperwasser, C.; Weinberg, R.A.; Lander, E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138, 645–659. [Google Scholar] [CrossRef] [PubMed]
- Ma, C.X.; Reinert, T.; Chmielewska, I.; Ellis, M.J. Mechanisms of aromatase inhibitor resistance. Nat. Rev. Cancer 2015, 15, 261–275. [Google Scholar] [CrossRef]
- Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983–3988, Erratum in Proc. Natl. Acad. Sci. USA 2003, 100, 6890. [Google Scholar] [CrossRef]
- Manuel Iglesias, J.; Beloqui, I.; Garcia-Garcia, F.; Leis, O.; Vazquez-Martin, A.; Eguiara, A.; Cufi, S.; Pavon, A.; Menendez, J.A.; Dopazo, J.; et al. Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin. PLoS ONE 2013, 8, e77281. [Google Scholar] [CrossRef]
- Morrison, B.J.; Schmidt, C.W.; Lakhani, S.R.; Reynolds, B.A.; Lopez, J.A. Breast cancer stem cells: Implications for therapy of breast cancer. Breast Cancer Res. 2008, 10, 210. [Google Scholar] [CrossRef] [PubMed]
- Hirao-Suzuki, M.; Koga, T.; Sakai, G.; Kobayashi, T.; Ishii, Y.; Miyazawa, H.; Takiguchi, M.; Sugihara, N.; Toda, A.; Ohara, M.; et al. Fatty acid 2-hydroxylase (FA2H) as a stimulatory molecule responsible for breast cancer cell migration. Biochem. Biophys. Res. Commun. 2020, 531, 215–222. [Google Scholar] [CrossRef]
- Zhang, X.; Yalcin, S.; Lee, D.F.; Yeh, T.Y.; Lee, S.M.; Su, J.; Mungamuri, S.K.; Rimmelé, P.; Kennedy, M.; Sellers, R.; et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat. Cell. Biol. 2011, 13, 1092–1099. [Google Scholar] [CrossRef]
- Kurosu, T.; Fukuda, T.; Miki, T.; Miura, O. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene 2003, 22, 4459–4468. [Google Scholar] [CrossRef]
- Kim, J.H.; Chae, M.; Kim, W.K.; Kim, Y.J.; Kang, H.S.; Kim, H.S.; Yoon, S. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br. J. Pharmacol. 2011, 162, 773–784. [Google Scholar] [CrossRef]
- Kim, K.Y.; Park, K.I.; Kim, S.H.; Yu, S.N.; Lee, D.; Kim, Y.W.; Noh, K.T.; Ma, J.Y.; Seo, Y.K.; Ahn, S.C. Salinomycin induces reactive oxygen species and apoptosis in aggressive breast cancer cells as mediated with regulation of autophagy. Anticancer Res. 2017, 37, 1747–1758. [Google Scholar] [CrossRef]
- Zerbini, L.F.; Wang, Y.; Czibere, A.; Correa, R.G.; Cho, J.Y.; Ijiri, K.; Wei, W.; Joseph, M.; Gu, X.; Grall, F.; et al. NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival. Proc. Natl. Acad. Sci. USA 2004, 101, 13618–13623, Erratum in Proc. Natl. Acad. Sci. USA 2004, 101, 15271. [Google Scholar] [CrossRef] [PubMed]
- Zhang, L.; Tao, L.; Ruan, J.; Li, W.; Wu, Y.; Yan, L.; Zhang, F.; Fan, F.; Zheng, S.; Wang, A.; et al. Xanthatin induces G2/M cell cycle arrest and apoptosis in human gastric carcinoma MKN-45 cells. Planta Med. 2012, 78, 890–895. [Google Scholar] [CrossRef] [PubMed]
- Zerbini, L.F.; Libermann, T.A. Life and death in cancer. GADD45 and are critical regulators of NF-κB mediated escape from programmed cell death. Cell Cycle 2005, 4, 18–20. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Cao, Y.; Luo, J.L.; Karin, M. IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc. Natl. Acad. Sci. USA 2007, 104, 15852–15857. [Google Scholar] [CrossRef] [PubMed]
- Liu, M.; Sakamaki, T.; Casimiro, M.C.; Willmarth, N.E.; Quong, A.A.; Ju, X.; Ojeifo, J.; Jiao, X.; Yeow, W.S.; Katiyar, S.; et al. The canonical NF-κB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 2010, 70, 10464–10473. [Google Scholar] [CrossRef] [PubMed]
- Takeda, S.; Yaji, K.; Matsumoto, K.; Amamoto, T.; Shindo, M.; Aramaki, H. Xanthocidin derivatives as topoisomerase IIα enzymatic inhibitors. Biol. Pharm. Bull. 2014, 37, 331–334. [Google Scholar] [CrossRef] [PubMed]
- Guzman, M.L.; Rossi, R.M.; Karnischky, L.; Li, X.; Peterson, D.R.; Howard, D.S.; Jordan, C.T. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005, 105, 4163–4169. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Takeda, S.; Hirao-Suzuki, M.; Shindo, M.; Aramaki, H. (–)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin. Curr. Issues Mol. Biol. 2022, 44, 3849-3858. https://doi.org/10.3390/cimb44090264
Takeda S, Hirao-Suzuki M, Shindo M, Aramaki H. (–)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin. Current Issues in Molecular Biology. 2022; 44(9):3849-3858. https://doi.org/10.3390/cimb44090264
Chicago/Turabian StyleTakeda, Shuso, Masayo Hirao-Suzuki, Mitsuru Shindo, and Hironori Aramaki. 2022. "(–)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin" Current Issues in Molecular Biology 44, no. 9: 3849-3858. https://doi.org/10.3390/cimb44090264
APA StyleTakeda, S., Hirao-Suzuki, M., Shindo, M., & Aramaki, H. (2022). (–)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin. Current Issues in Molecular Biology, 44(9), 3849-3858. https://doi.org/10.3390/cimb44090264